Clinical Trial: Single Intravitreal Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07064759) titled 'Single Intravitreal Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration' on July 07.

Brief Summary: A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Macular Neovascularization Secondary to Age-Related Macular Degeneration

Intervention: BIOLOGICAL: 4D-150 IVT (3E10 vg/eye)

If randomized to the 4D-150 treatment arm, 4D-150 will be administered at the assigned dose level as a single dose IVT injection on Da...